Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer

NCT07021911 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Campus Bio-Medico as lead sponsor.

NCT NCT07021911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07021911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
Lead sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Phase
Observational
Overall status
Recruiting
Start date
May 17, 2023
Completion date
May 17, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, radiotherapy; complications